RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion BPC 157 promoted in vivo and in vitro angiogenesis. a Representative Download Scientific Diagram Peptide Therapy in The Colony TX The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling